[Asia Economy Reporter Minwoo Lee] In China, human-to-human transmission of 'Wuhan pneumonia (novel coronavirus)' has been officially confirmed, and the death toll has risen to six. Related pharmaceutical stocks are soaring amid fears of a recurrence of the 2003 'SARS (Severe Acute Respiratory Syndrome)' and the 2015 'MERS (Middle East Respiratory Syndrome)' outbreaks.
At around 9:50 a.m. on the 22nd, the stock price of Seorin Bio, a virus disinfectant manufacturer, hit the upper limit, rising 29.88% from the previous day to 12,300 won. Ilshin Bio, a bio equipment manufacturer, is also trading at 2,645 won, up 18.08% from the previous day.
Other pharmaceutical-related stocks such as Nivek (10.65%), KM Pharmaceutical (9.54%), and GeneOne Life Science (7.76%) are also on the rise.
Earlier, on the 20th, the Korea Centers for Disease Control and Prevention announced that a Chinese national woman who entered Incheon Airport from Wuhan, China on the 19th was infected with Wuhan pneumonia. The infectious disease crisis alert level was also raised from 'interest' to 'caution.' So far, six people have died from Wuhan pneumonia in China.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
